CTS CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $541.3M | $514.8M | $550.4M | $586.9M | $512.9M |
| Cost of revenue | $333.3M | $327.2M | $359.6M | $376.3M | $328.3M |
| Gross profit | $208.0M | $187.6M | $190.9M | $210.5M | $184.6M |
| Selling, general & administrative | $98.7M | $88.3M | $83.8M | $91.5M | $82.6M |
| Research and development | $25.3M | $23.4M | $24.9M | $24.1M | $23.9M |
| Operating income | $82.6M | $71.2M | $75.1M | $93.0M | $76.5M |
| Interest expense | $4.3M | $4.2M | $3.3M | $2.2M | $2.1M |
| Pretax income | $83.8M | $68.6M | $75.2M | $80.7M | -$60.9M |
| Income tax expense | $18.5M | $13.1M | $14.6M | $21.2M | -$19.0M |
| Net income | $65.3M | $55.5M | $60.5M | $59.6M | -$41.9M |
| Balance Sheet | |||||
| Cash and equivalents | $82.3M | $94.3M | $163.9M | $156.9M | $141.5M |
| Current assets | $252.7M | $242.2M | $319.3M | $325.8M | $289.1M |
| Total assets | $764.3M | $765.4M | $741.2M | $748.5M | $664.5M |
| Current liabilities | $109.7M | $98.5M | $97.0M | $112.5M | $114.1M |
| Total liabilities | $212.5M | $237.2M | $214.3M | $242.3M | $200.9M |
| Stockholders' equity | $551.8M | $528.2M | $526.8M | $506.2M | $463.6M |
| Cash Flow Statement | |||||
| Cash from operations | $102.1M | $98.2M | $88.8M | $121.2M | $86.1M |
| Depreciation and amortization | $34.5M | $30.9M | $28.7M | $29.8M | $26.9M |
| Capital expenditure | $15.7M | $18.6M | $14.7M | $14.3M | $15.6M |
| Free cash flow | $86.4M | $79.6M | $74.1M | $106.9M | $70.5M |
| Dividends paid | $4.8M | $4.9M | $5.0M | $5.1M | $5.2M |
| Share repurchases | $56.2M | $42.6M | $40.9M | $21.4M | $8.8M |
| Impairments | — | — | — | $0 | $0 |
Shares outstanding 28.6M · Free float 92.6%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.